Premium
BeEAM (bendamustine, etoposide, cytarabine, melphalan) prior to autologous stem cell transplant for chemosensitive relapses in patients with follicular lymphoma: a prospective multicentre phase II study in Lymphoma Study Association centres †
Author(s) -
Ghesquières Hervé,
Dalban Cécile,
NicolasVirelizier Emmanuelle,
Jardin Fabrice,
Le Bras Fabien,
Le Gouill Steven,
Casasnovas Olivier,
Vizoso Séraphine,
Hernandez Caroline,
Metzger Séverine,
Pérol David,
Cartron Guillaume
Publication year - 2021
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.17279
Subject(s) - bendamustine , medicine , melphalan , etoposide , follicular lymphoma , transplantation , salvage therapy , autologous stem cell transplantation , cytarabine , oncology , gastroenterology , surgery , regimen , chemotherapy , lymphoma , rituximab